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regarding the effect of diet on health (all p < 0.001; consistent across
subgroups).
Conclusions: Diet and nutrition education present an important target for
primary care of people with SMI. Targeting at-risk populations also pre-
sents an opportunity for prevention. Although research has identiﬁed the
contribution of individual nutrients to mental health, further research
needs to elucidate the role of whole diet and nutrition and mental illness.
Funding source(s): N/A.
MACRO AND MICRONUTRIENT DIFFERENCES OF ADdLIBITUM
PALAEOLITHIC VS AUSTRALIAN GUIDE TO HEALTHY EATING DIETS
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Background/Aims: To investigate the differences in the macronutrient
composition between the palaeolithic and AGHE Diet.
Methods: Thirty nine healthy women (mean ± SD age 47 ± 13 years, BMI
27 ± 4 kg/m2) were randomised to either the palaeolithic (n¼ 22) or AGHE
diet (n ¼ 17) for 4-weeks. A 3-day weighed food record (WFR) was
collected pre- and post-intervention. WFR were analysed using Food-
Works (AUSNUT2007, Xyris Software, QLD, 2012). Within group analysis
was performed using paired t-tests, between group analysis was con-
ducted using Mann-Whitney and independent t-tests.
Results: The palaeolithic group had a lower intake of carbohydrate (28 ±
8% vs 41 ± 9% of energy, p < 0.05), and higher intake of fat (40 ± 10% vs 33 ±
7%, p < 0.05) and protein (27 ± 7% vs 22 ± 6%, p < 0.05) compared to AGHE.
Within group analyses showed reductions in saturated fat intake in both
groups (p < 0.05) but no change to dietary ﬁbre or total sugars. Within the
palaeolithic group, there were signiﬁcant reductions in energy, thiamin,
riboﬂavin, sodium and calcium and increases in vitamins C, E and b-
carotene (all p < 0.05).
Conclusions: Despite the reduction in carbohydrates due to the removal of
whole grain cereals and dairy, ﬁbre intake was not impacted in the
palaeolithic group. However, signiﬁcant reductions in B vitamins and
calcium were seen. Further research to explore the health implications
related to long-term palaeolithic dietary patterns are recommended.
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LONG-TERM EFFECTS OF VERY LOW- AND HIGH-CARBOHYDRATE
WEIGHT LOSS DIETS ON MOOD RESPONSE IN OBESE ADULTS WITH
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Nutrition, SA, Australia; 2Department of Medicine, University of South
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Background/Aims: Very low carbohydrate, high fat (LC) diets are used for
T2DM management. Previous research has shown compared to a high
carbohydrate, low fat (HC) diet, a LC diet have less favourable effects on
mood state in obese patients without diabetes. However, effects in T2DM
at heightened risk of mood disturbance and depression remain unknown.
This study compared the effects of an energy-restricted LC diet and an
isocaloric HC diet on mood state over 12-months.
Methods: Subjects (n ¼ 115; mean ± SD age: 58 ± 7 years; BMI: 34.6 ± 4.3
kg/m2; HbA1c: 7.3 ± 1.1%) were randomly assigned to consume either a
hypocaloric (~6-7 MJ), planned isocaloric LC or HC diet, combined with
exercise (3 day/week) for 1-yr. Body weight and psychological mood state
measured by validated questionnaires - Proﬁle of Mood States (POMS), Beck
Depression Inventory (BDI) and Spielberger State-Trait Anxiety Inventory
(STAI) were assessed monthly. Data was analysed with mixed models.
Results: Overall weight loss was 9.5 ± 0.5 kg; no difference between
groups (p ¼ 0.91). Over the course of the study there were signiﬁcant
improvements in BDI and the POMS scores (total mood disturbance and 6subscales (anger-hostility, confusion-bewilderment, depression-dejection,
fatigue, vigor and tension-anxiety), p < 0.05 for time, effect size: 14-43%.
STAI remained largely unchanged (p ¼ 0.08 time). There was no diet effect
on the responses for any of the outcomes (p ¼ 0.22 time  diet).
Conclusions: Over 1 year both diets achieved substantial weight loss and
similar improvements in mood state and affect. This suggests either an LC
or HC diet when combined with exercise in a lifestyle modiﬁcation pro-
gram improve psychological wellbeing in T2DM.
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RICE INTAKE IS INVERSELY RELATED TO CARDIOVASCULAR MORTALITY
AMONG CHINESE ADULTS
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Background/Aims: Few studies have assessed the association between
rice intake and mortality. The results from these studies are inconsistent.
We assessed whether rice intake was associated with CVD mortality,
cancer mortality and all-cause mortality in a Chinese population.
Methods: We prospectively studied 2,832 adults aged 20 years and above
with a mean follow up of 10 years. Rice intake was assessed by 3-day
weighed food record (WFR) in 2002. HRs and 95%CI were calculated by
competing risks regression (CVD and cancer mortality) and Cox propor-
tional hazards analysis (all-cause mortality). A meta-analysis on rice intake
and CVD mortality was conducted.
Results: We documented 184 deaths (70 CVD deaths and 63 cancer
deaths) during 27,741 person-years of follow-up. Rice intake was inversely
associated with CVDmortality. HRs for CVD mortality across tertiles of rice
intake was 1.00, 0.53 (95%CI: 0.25, 1.11), and 0.34 (95%CI: 0.13, 0.90), p for
trend 0.019. No association between rice intake and all-cause mortality
was found. There was a trend of increased risk of cancer mortality among
those with high intake of rice. In the meta-analysis which included three
prospective studies, a high rice intake tended to be associated with
reduced CVD mortality with pooled RR of 0.91 (95%CI: 0.76, 1.11).
Conclusions: Rice intake was inversely related to CVD mortality. There
was no association between rice intake and cancer- or all-cause mortality.
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DIETARY PROTEIN AND THE METABOLIC SYNDROME: A RANDOMISED
CONTROLLED TRIAL
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Background/Aims: The aim of this study was to investigate the effect of
three diets controlled for saturated fat (SFA) and varying in type (animal vs.
plant) and amount (18% vs. 27%) of dietary protein on metabolic syndrome
(MetS) criteria.
Methods: Sixty-two overweight adults with MetS (age: 30 - 60 y; mean ±
SD BMI: 34.8 ± 0.5 kg/m2) consumed a healthy American diet (HAD) for 2
weeks before being randomised to either a modiﬁed-DASH diet rich in
plant protein (M-DASH: 18% protein, 2/3 plant sources, n ¼ ¼ 21); a
modiﬁed-DASH diet rich in animal protein (BOLD, 19% protein, 2/3 animal
sources, n ¼ 20); and a moderate protein diet (BOLD+: 27% protein, 2/3
animal sources, n ¼ 21). Diets were compared at three levels of energy
balance: controlled weight maintenance (WM), controlled weight loss
including exercise (WL), and free-living weight loss (FL). Differences in
MetS criteria, cholesterol, insulin and adiposity at the end of each phase
were tested using repeated measure ANCOVA (adjusted for age and sex).
Results: While no between groups differences were observed, there was a
signiﬁcantmain effect of phase (p< 0.01) for all endpoints except for insulin.
After the WM phase, all groups had a MetS prevalence of 80-90%, which
decreased signiﬁcantly to 50-60% after WL and maintained through FL.
